Skip to main content

Table 1 Patients and tumor characteristics

From: ABCG2 is a potential prognostic marker of overall survival in patients with clear cell renal cell carcinoma

Parameters Value
Number of patients 120
Number of males (%) 83 (70%)
Median age at surgery (years) (IQR) 56 (50–65)
Median follow-up (months) (IQR) 92.5 (62.3–99.4)
Median tumor size (cm) (IQR) 5.0 (3.5–7.0)
Symptoms on first diagnosis (%) 47 (40%)
Tumor stage (TNM2009)  
 pT1a 37(30.8%)
 pT1b 55 (45.8%)
 pT2 18 (15%)
 pT3 10 (8.3%)
Regional lymph node metastasis (TNM 2009) (%) 3 (2.5%)
Distant metastasis on first diagnosis (TNM 2009) (%) 19 (16%)
Fuhrman grade  
 1 18 (15%)
 2 70 (58.3%)
 3 25 (20.8%)
 4 7 (5.8%)
Type of surgery (%)  
 Radical Nephrectomy 114 (95%)
 Partial Nephrectomy 6 (5%)
ABCG2 (%)  
 (−) 57 (48%)
 (+) 52 (43%)
 (++) 11 (9.2%)